MELO SOINS: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MELO SOINS
Largest movements
- Cash +€33,485
up €33,485 (+165.5%), from €20,238 to €53,723
mainly Net result for the year (+€42,965) and Other debts (+€354)
- Deferred charges and accrued income +€6,452
up €6,452 (+124.5%), from €5,184 to €11,636
- Tangible fixed assets +€1,902
new in 2025: €1,902
- Receivables within one year +€1,143
new in 2025: €1,143
of which Trade receivables: +€785
- Profit (loss) carried forward +€42,965
up €42,965 (+276.3%), from €15,548 to €58,513
- Gross operating margin +€32,572
up €32,572 (+142.2%), from €22,903 to €55,475
- Taxes +€4,524
up €4,524 (+65.3%), from €6,927 to €11,451
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €25,422 | €68,462 | +€43,040 | +169.3% |
| Fixed assets | 21/28 | - | €1,959 | +€1,959 | |
| Tangible fixed assets | 22/27 | - | €1,902 | +€1,902 | |
| Furniture and vehicles | 24 | - | €1,902 | +€1,902 | |
| Financial fixed assets | 28 | - | €57 | +€57 | |
| Current assets | 29/58 | €25,422 | €66,502 | +€41,080 | +161.6% |
| Amounts receivable within one year | 40/41 | - | €1,143 | +€1,143 | |
| Trade receivables | 40 | - | €785 | +€785 | |
| Other amounts receivable | 41 | - | €358 | +€358 | |
| Cash at bank and in hand | 54/58 | €20,238 | €53,723 | +€33,485 | +165.5% |
| Deferred charges and accrued income | 490/1 | €5,184 | €11,636 | +€6,452 | +124.5% |
| Total equity and liabilities | 10/49 | €25,422 | €68,462 | +€43,040 | +169.3% |
| Equity | 10/15 | €17,548 | €60,513 | +€42,965 | +244.9% |
| Contributions | 10/11 | €2,000 | €2,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €15,548 | €58,513 | +€42,965 | +276.3% |
| Amounts payable | 17/49 | €7,874 | €7,949 | +€74 | +0.9% |
| Amounts payable within one year | 42/48 | €7,874 | €7,949 | +€74 | +0.9% |
| Trade debts | 44 | €240 | €151 | -€89 | -37.2% |
| Suppliers | 440/4 | €240 | €151 | -€89 | -37.2% |
| Taxes, remuneration and social security | 45 | €6,927 | €6,736 | -€191 | -2.8% |
| Taxes | 450/3 | €6,927 | €6,736 | -€191 | -2.8% |
| Other amounts payable | 47/48 | €707 | €1,062 | +€354 | +50.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | - | €345 | +€345 | |
| Other operating charges | 640/8 | €311 | €490 | +€179 | +57.5% |
| Gross operating margin | 9900 | €22,903 | €55,475 | +€32,572 | +142.2% |
| Operating profit (loss) | 9901 | €22,592 | €54,640 | +€32,048 | +141.9% |
| Financial income | 75/76B | - | €17 | +€17 | |
| Recurring financial income | 75 | - | €17 | +€17 | |
| Financial charges | 65/66B | €118 | €240 | +€123 | +104.4% |
| Recurring financial charges | 65 | €118 | €240 | +€123 | +104.4% |
| Profit (loss) for the period before taxes | 9903 | €22,475 | €54,416 | +€31,942 | +142.1% |
| Income taxes | 67/77 | €6,927 | €11,451 | +€4,524 | +65.3% |
| Profit (loss) for the period | 9904 | €15,548 | €42,965 | +€27,418 | +176.3% |
| Profit (loss) for the period to be appropriated | 9905 | €15,548 | €42,965 | +€27,418 | +176.3% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 12 October 2026 via checked.be.